Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd.

Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd. is a large modern enterprise dedicated to the modernization of traditional Chinese medicine with a history of over 300 years. It is affiliated with Guangzhou Pharmaceutical Holdings Limited and is a national high-tech enterprise, ranking among the top 100 pharmaceutical companies in China, and is the largest R&D and industrialization base for anti-diabetic traditional Chinese medicine in the country.
Inheriting civilization and conforming to nature, Baiyunshan Zhongyi, a 'China Time-honored Brand', is regarded as a 'living fossil' in the development of Lingnan traditional Chinese medicine. Its founder, Huang Zhonghuang Pharmacy, was established in 1662 (the first year of the Kangxi reign in the Qing Dynasty), and Baozhitang Pharmacy was established in 1669. Both enjoyed widespread fame and radiated brilliance in the history of Chinese medicine. Traditional ancient prescriptions such as Angong Niuhuang Wan and Baoying Dan have been passed down to this day as cultural heritage of Lingnan traditional Chinese medicine.
Technological innovation and brand excellence. Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd. owns two well-known trademarks in China: 'Baiyunshan' and 'Zhongyi'. It is a national high-tech enterprise and a pilot enterprise for intellectual property rights among national enterprises and institutions. It extensively adopts traditional Chinese medicine prescriptions and draws on the expertise of contemporary renowned physicians. With technological innovation as a means, it has formed a product line focusing on five major categories for treating diabetes, digestive system diseases, gynecological diseases, surgical conditions, and ENT disorders, encompassing more than 130 varieties across 6 dosage forms. It has established a systematic intellectual property protection system with over 100 patents. Its national key new product, Xiaoke Pill, has won the 'China Patent Excellence Award'. It has built an enterprise technology innovation platform centered on the 'Guangdong Province Diabetes Drug Engineering Technology R&D Center', conducting evidence-based medical research on Xiaoke Pill (National 863 Program project), pharmacoeconomic studies, and post-marketing re-evaluation. Advanced technologies such as automated production systems and online monitoring and control are widely applied in the production process. It has formed an ecological industry chain integrating medicinal material base construction, scientific R&D, production, and sales. Baiyunshan Zhongyi has been honored with titles such as 'China Quality 500', 'Top Ten Quality Brands in China's Pharmaceutical Industry', and its Xiaoke Pill, Weinaian Capsules, and Ruhusanjie Tablets are recognized as 'High-tech Products of Guangdong Province'. The Baiyunshan Zhongyi brand is truly a quality brand trusted by consumers in China.
Caring for health, always consistent. Through over 300 years of historical changes, Baiyunshan Zhongyi has adhered to its corporate purpose of 'Caring for health, always consistent', promoted the spirit of 'Unity, Exploration, Pragmatism, and Efficiency', and under the vision of 'developing into a large modern pharmaceutical enterprise with strong social responsibility', it fulfills its social responsibilities:
- Participating in the International Diabetes Federation's 'Blue Light Action' to raise public awareness of diabetes prevention and treatment through health education;
- Participating in the large-scale TCM science popularization campaign 'TCM China Journey' hosted by the Ministry of Health and the Publicity Department of the Central Committee;
- Undertaking the 'Health New Long March' national grassroots diabetes prevention and treatment education project of the Ministry of Health;
- Co-organizing the 'Building a Healthy Road' national community health program for diabetes prevention and control;
- Launching the 'Drug Packaging Environmental Recycling Mechanism' jointly with the China Environmental Protection Federation;
- Establishing the Guangyao Baiyunshan Zhongyi Xiaoke (Diabetes) Fund with the Guangdong Charity Federation, dedicated to providing professional assistance to diabetic patients;
...
Harmonious coexistence, mutual prosperity. Baiyunshan Zhongyi actively promotes the modernization of the TCM industry with technological innovation and resource advantages, providing high-quality products and services to society. It strives to build 'a production base for anti-diabetic drugs, a base for gynecological drugs, and a base for digestive system drugs', creating lasting value for society. It aims to build a leading drug R&D and production enterprise, providing a platform for employees to realize their value, and becoming one of the most powerful promoters of TCM modernization in China. The Zhongyi brand constructs a harmonious value chain with 'government-health industry-employees-consumers-society'.
Inheritance and innovation, continuous development. Baiyunshan Zhongyi is committed to building a modern large enterprise that integrates industrialization, informatization, and TCM culture, producing high-quality modern TCM products, and becoming a 'healthy lifestyle partner' in consumers' hearts. Standing at the forefront of human health, Baiyunshan Zhongyi ensures sustainable brand development and continuous innovation!